Steve Kim

6PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus.

Gabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak

|Dec 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Asfar S Azmi, Husain Yar Khan, Irfana Muqbil

|Dec 05, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors.

Gabriel Mpilla, Amro Aboukameel, Irfana Muqbil

|Oct 02, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.

Rachel Sexton, Zaid Mahdi, Rahman Chaudhury

Pageof 1